Smith, C., Weinberg, A., Forster, J. E., Levin, M. J., Davies, J., Pappas, J., . . . McFarland, E. J. (2016). Maternal Lopinavir/Ritonavir Is Associated with Fewer Adverse Events in Infants than Nelfinavir or Atazanavir. Infect Dis Obstet Gynecol.
Citação norma ChicagoSmith, Christiana, et al. "Maternal Lopinavir/Ritonavir Is Associated With Fewer Adverse Events in Infants Than Nelfinavir or Atazanavir." Infect Dis Obstet Gynecol 2016.
Citação norma MLASmith, Christiana, et al. "Maternal Lopinavir/Ritonavir Is Associated With Fewer Adverse Events in Infants Than Nelfinavir or Atazanavir." Infect Dis Obstet Gynecol 2016.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.